GoodRx Holdings Inc.

07/26/2024 | Press release | Distributed by Public on 07/26/2024 10:20

Which Diabetes Medications Can Cause Weight Loss or Gain

Key takeaways:

  • Diabetes medications can cause weight changes by affecting your body's insulin levels and how your body uses glucose (sugar).

  • Mounjaro (tirzepatide), Ozempic (semaglutide), and Trulicity (dulaglutide) are examples of diabetes medications that can cause significant weight loss. Metformin and Jardiance (empagliflozin) may also cause weight loss but not as much.

  • Insulin and glipizide (Glucotrol XL) are common diabetes medications that can cause weight gain. But the amount of weight gained with these medications is unique for everyone.

Access savings to related medications

info_outlinedPromotional disclosure
simpson33/iStock via Getty Images

More than 1 in 10 people in the U.S. are living with diabetes. Diabetes is a condition that happens when your body can't make or use insulin. Without insulin, the body's blood glucose (blood sugar) rises to unsafe levels. The majority of people living with diabetes have Type 2 diabetes.

Some diabetes medications can affect your body weight. This could mean either weight loss or weight gain. But not all diabetes medications cause weight changes. Some have little effect on body weight for most people who take them.

GoodRx Health

Which diabetes medications can cause weight loss?

There are five types of diabetes medications that can cause weight loss. These medications each work differently from each other.

Diabetes on GoodRx

Learn more about diabetes savings and resources.

1. GLP-1 agonists like Ozempic

Glucagon-like peptide-1 (GLP-1) agonists are a group of medications growing in popularity when it comes to diabetes and weight loss. GLP-1 is a hormone in our bodies that tells our pancreas to release insulin after we eat. It also lowers the amount of new glucose your liver produces. And it helps us feel full in between meals. GLP-1 agonists act like GLP-1 does in the body.

Some studies have shown that people with diabetes lost as much as 14 lbs when using a GLP-1 agonist. Other studies have suggested GLP-1 agonists cause more modest weight loss (about 2 lbs). The amount of weight loss can vary, depending on which medication and what dose is used. Many studies in people with diabetes that looked at weight loss from GLP-1 agonists ran for between 6 and 12 months.

There are several GLP-1 agonists FDA-approved for Type 2 diabetes, including:

EXPERT PICKS: WHAT TO READ NEXT
  • Which diabetes injections cause weight loss? Glucagon-like peptide-1 (GLP-1) agonists can lead to significant weight loss. Read more about the available GLP-1 agonists and how they compare.

  • How does it feel to take Ozempic? Three people share their experiences with Ozempic, which can be beneficial for many people living with Type 2 diabetes.

  • What else can cause weight gain? Insulin is only one type of medication that has this side effect. Read more about which medications can cause weight gain.

Good to know: Two GLP-1 agonists are also approved for chronic weight management: semaglutide (sold as Wegovy) and liraglutide (sold as Saxenda). These medications are administered at higher doses when they're being used for weight loss. And they're not interchangeable with the versions used to treat Type 2 diabetes. Using Ozempic or Victoza for weight loss is an off-label use of the medications.

2. Mounjaro

Mounjaro (tirzepatide) works like GLP-1 agonists - but with an added boost. It acts like GLP-1 and another hormone called glucose-dependent insulinotropic polypeptide (GIP). This dual effect can help provide better blood glucose-lowering effects. It can also lead to greater weight loss than with GLP-1 agonists like Ozempic. In studies, people taking Mounjaro lost an average of 16 lbs to 25 lbs, depending on the dose.

The active ingredient in Mounjaro - tirzepatide - is also approved for weight loss. But it's approved under the brand name Zepbound. Similar to the GLP-1 agonists mentioned above, using Mounjaro for weight loss is an off-label use of the medication. Mounjaro is only approved for Type 2 diabetes.

3. Metformin

Metformin is another diabetes medication that can cause weight loss as a side effect for some people. It's one of the most prescribed diabetes medications because it's effective for lowering blood glucose and has lower-cost generic versions available. It mainly lowers the amount of glucose made and absorbed by the body, and it makes the body more sensitive to its natural insulin.

Metformin's weight loss is more modest than the medications listed above. And not everyone loses weight while taking it. But studies have shown some people may lose up to 6 lbs after taking metformin for a year.

4. SGLT2 inhibitors like Jardiance

Another group of diabetes medications called sodium-glucose cotransporter 2 (SGLT2) inhibitors can cause weight loss. SGLT2 inhibitors remove glucose from the blood through urine. Less glucose in the blood means less glucose is available to be turned into fat cells. And this can lead to modest weight loss for some people. People taking SGLT2 inhibitors may lose about 4 lbs to 6 lbs while taking them.

Examples of SGLT-2 inhibitors include:

5. Symlin

Symlin (pramlintide) is a lab-made form of the hormone amylin. Amylin slows down food movement through the stomach and prevents your liver from making glucose. Symlin acts like amylin does in the body. This medication can cause most people with diabetes to lose up to 4 lbs. For people with diabetes who are also considered obese, they may lose up to 7 lbs with Symlin.

Which diabetes medications can cause weight gain?

There are four main groups of diabetes medications that can cause weight gain. They all work by affecting insulin in the body. And as we'll discuss later, medications that affect insulin levels in your body can cause weight gain.

1. Insulin

Insulin is one of the most commonly used diabetes medications. Most forms of insulin can make people gain weight. People taking insulin for Type 2 diabetes gain an average of 4 lbs during the first year they're using it. But some people can gain 11 lbs or more during this timeframe.

2. Sulfonylureas like glipizide

Sulfonylureas are another common group of diabetes medications that can cause weight gain. They work by stimulating the pancreas to release insulin. On average, people taking sulfonylureas gain about 5 lbs.

Examples of sulfonylureas include:

3. Thiazolidinediones like pioglitazone

Another group of medication that causes diabetes weight gain is thiazolidinediones (TZDs or "glitazones"). They lower blood glucose by making the body more sensitive to insulin. They also affect genes that are involved in fat cell formation. People taking TZDs can gain about 6 lbs to 9 lbs during the first 6 months and up to 11 lbs over 3 to 5 years.

The two FDA-approved TZDs are:

4. Meglitinides like repaglinide

Meglitinides ("glinides") are another group of diabetes medications. Similar to sulfonylureas, they cause the pancreas to release more insulin. People can gain up to 7 lbs during the first 3 months of starting glinides.

The two available glinides are:

Why do diabetes medications cause weight changes for some people?

Diabetes medications can cause weight changes by affecting how glucose is used by the body. Insulin is a hormone that helps your body to turn glucose from food into energy for your cells. Insulin helps glucose move from your blood into your cells. This movement lowers your blood glucose.

But when there's too much glucose in the blood, insulin tells your liver to turn that glucose into fat cells. These extra fat cells can lead to weight gain over time.

When people use insulin as a medication, it acts like natural insulin. Until your blood glucose is better balanced, this glucose-into-fat process can keep happening. This is why insulin's weight gain side effect is most expected when you first start it. This side effect also applies to medications that tell your body to make more insulin.

On the flip side, some diabetes medications can cause weight loss by getting rid of extra glucose in your body or lowering how much glucose your liver makes. Less glucose in the blood means there's less glucose available to change into fat. So if a medication works by removing glucose from the blood or lowering how much glucose is made, weight loss is a possible side effect.

Which diabetes medications are likely to have little or no effect on your weight?

Some diabetes medications have little to no effect on weight for most people. Healthcare professionals sometimes call these "weight-neutral" diabetes medications.

Dipeptidyl peptidase-4 (DPP-4) inhibitors like Januvia

Dipeptidyl peptidase-4 (DPP-4) inhibitors ("gliptins") are a commonly-used group of diabetes medications. Sitagliptin (Januvia, Zituvio) is the most well-known DPP-4 inhibitor. These medications lower blood glucose by helping to raise natural levels of GLP-1 in the body.

Studies have shown DPP-4 inhibitors have little effect on body weight. So while medications such as sitagliptin likely won't cause weight loss, they shouldn't cause weight gain either.

Other DPP-4 inhibitors include:

Which side effect is more common with diabetes medications: Weight gain or weight loss?

Neither weight gain nor weight loss is a more common side effect when comparing all diabetes medications. And not everyone experiences body weight changes from diabetes medications. There are several different types of medications available. They work in different ways to help lower blood glucose. The risk of weight gain or weight loss depends on the medication and lifestyle factors, like diet and exercise.

Weight gain can discourage people from continuing their medications. And when people stop taking their diabetes medications, their risks of diabetes complications go up. Make sure to let your healthcare team know if you notice any changes to your weight that you're uncomfortable with. They may recommend changes to your medications to help with this side effect.

How long does it take for diabetes medications to cause weight loss?

Body weight changes may become noticeable within the first few months of starting a diabetes medication. But you may not notice significant weight loss for closer to a year (or longer) with GLP-1 agonists or Mounjaro.

For example, people taking Ozempic lost an average of 8 lbs after 30 weeks (about 7 months) with the 0.5 mg per week dosage. At higher doses (1 mg to 2 mg per week), people lost around 13 lbs to 15 lbs after 40 weeks (about 9 months). With Mounjaro, people lost between 15% and 20% of their starting body weight after taking the medication for 72 weeks (more than 16 months).

Can weight gain from diabetes medication be prevented?

Weight gain from diabetes medications may be preventable. A diabetes-friendly diet and regular exercise play an important role in managing diabetes. These healthy lifestyle changes can help lower blood glucose and lower or maintain weight. But in some cases, these aren't enough for everyone.

It's best to discuss with your healthcare team what changes would be best for you. They may suggest changing your current diabetes medication regimen. Adding or switching to a diabetes medication that causes weight loss may also be an option. But you shouldn't try to adjust your medications or dosages without your prescriber's OK.

Frequently asked questions

How do you qualify for Ozempic?
expand_more

You may qualify for Ozempic if you're an adult living with Type 2 diabetes. This is one of the medication's FDA-approved uses. Ozempic is also approved to help lower the risk of serious cardiovascular issues in adults who have both Type 2 diabetes and heart disease. There are no body weight requirements to qualify for Ozempic.

Can a healthcare professional prescribe Ozempic if you don't have diabetes?
expand_more

Yes, healthcare professionals can prescribe Ozempic to people without diabetes. This is called off-label prescribing, and it's not illegal to do this. Just keep in mind that your insurance may not cover Ozempic if you don't have Type 2 diabetes.

The bottom line

Some diabetes medications can cause weight loss or weight gain. Mounjaro (tirzepatide), Ozempic (semaglutide), and Trulicity (dulaglutide) can lead to significant weight loss. Metformin and medications like Jardiance (empagliflozin) can also promote weight loss, but not as much. On the flip side, sulfonylureas, glinides, and insulin typically cause weight gain. Some medications, such as Januvia (sitagliptin), don't usually cause weight loss or weight gain.

Eating a diabetes-friendly diet and exercising are important in maintaining a healthy weight. Work closely with your healthcare team to determine the best diabetes treatment regimen for you.

References

American Diabetes Association. (n.d.). Statistics about diabetes.

Apovian, C. M., et al. (2019). Body weight considerations in the management of type 2 diabetes. Advances in Therapy.

View All References (18)
expand_more

Balkau, B., et al. (2014). ​​Factors associated with weight gain in people with type 2 diabetes starting on insulin. Diabetes Care.

Black, C., et al. (2007). Meglitinide analogues for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews.

Collins, L., et al. (2024). Glucagon-like peptide-1 receptor agonists. StatPearls.

Diabetes Prevention Program Research Group. (2012). Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study. Diabetes Care.

Dicker, D. (2011). DPP-4 Inhibitors: Impact on glycemic control and cardiovascular risk factors. Diabetes Care.

Eggleton, J. S., et al. (2023). Thiazolidinediones. StatPearls.

Fisman, E. Z., et al. (2021). The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: A novel cardiometabolic therapeutic prospect. Cardiovascular Diabetology.

Hirst, J. A., et al. (2013). Estimating the effect of sulfonylurea on HbA1c in diabetes: A systematic review and meta-analysis. Diabetologia.

Hoogwerf, B. J., et al. (2008). Pramlintide, the synthetic analogue of amylin: Physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk. Vascular Health and Risk Management.

Kasina, S. V. S. K., et al. (2023). Dipeptidyl peptidase IV (DPP IV) inhibitors. StatPearls.

Ko, K. D., et al. (2017). Does weight gain associated with thiazolidinedione use negatively affect cardiometabolic health?Journal of Obesity and Metabolic Syndrome.

Lee, N. J., et al. (2010). Efficacy and harms of the hypoglycemic agent pramlintide in diabetes mellitus. Annals of Family Medicine.

MacFarlane, S. I. (2009). Insulin therapy and type 2 diabetes: Management of weight gain. Journal of Clinical Hypertension.

Novo Nordisk. (2023). Ozempic - semaglutide injection, solution [package insert].

Ribola, F. A., et al. (2017). Effects of SGLT2 inhibitors on weight loss in patients with type 2 diabetes mellitus. European Review for Medical and Pharmacological Sciences.

Schmitz, O., et al. (2004). Amylin agonists: A novel approach in the treatment of diabetes. Diabetes.

Trujillo, J. M., et al. (2021). GLP-1 receptor agonists: an updated review of head-to-head clinical studies. Therapeutic Advances in Endocrinology and Metabolism.

U.S. Food and Drug Administration. (2018). Sodium-glucose cotransporter-2 (SGLT2) inhibitors.

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

Was this page helpful?

thumb_up_outlinedthumb_down_outlined
print_outlinedemail_outlined

Learn How to Lower Your A1C

Join our 12-week newsletter series that has the lifestyle, diet, and medication information you need to help lower your A1C.
Email address
Subscribe
I would also like to sign up for a free GoodRx account

By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.